Atom, Jmho...
I would say this is obviously "active stuff" as the target dates are Jan to Mar 2021. Banks involved with NYSE Big Pharma IPO? Darn close to a prospectus and GEM/insiders have the votes anyway, IMO.
Maybe there will be more info at the 'Extraordinary" meeting besides salaries.
m52, Jmho...
After the consolidation about $5 @ 300M. With Good data and minor issues, $7 to $20 plus.?. + + if there is great Data with production and distribution physically started and/or with a quick path to revenues. IMHO...
That's as value a added to whatever the NRX side of a merge/IPO combination brings to the alluded NYSE Big Pharma deal. Fuzzy crystal balls, #'s juggling, opinions...